Further to DrugAlert volume 804, HPS Pharmacies wish to advise that suppliers are continuing to experience a supply interruption for amoxicillin + clavulanic acid 875mg/125mg tablets.

Product ARTG Current Status
Alphaclav Duo Forte 230396 Early November 2022
Amclavox Duo Forte 288119 Late November 2022
AmoxyClav Generichealth 875/125 255076 Late October 2022
APX-Amoxicillin/Clavulanic Acid 875/125 351833 Early December 2022
Augmentin Duo Forte 54900 Mid-September 2022
Curam Duo Forte 198109 Early October 2022

This supply interruption is due to an unexpected increase in demand.

An internationally registered brand of amoxicillin + clavulanic acid 875mg/125mg tablets has been approved for supply under Section 19A of the Therapeutic Goods Act 1989.

Retain this notice in a prominent position, including in other related business units until supplies return to normal. Report any problems identified with medicines, vaccines or medical devices to the TGA.

Should you require further information regarding this matter, please contact your pharmacist at HPS Pharmacies.

Subscribe Knowledge Centre Updates

Enter your details to receive Knowledge Centre updates